Cover Image

Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy

Saved in:

Bibliographic Details
Main Authors:	M. Peluso (Author), P. Bacchetti (Author), K. Ritter (Author), S. Beg (Author), P. Hunt (Author), T. Henrich (Author), J. Siliciano (Author), R. Siliciano (Author), G. Laird (Author), S. Deeks (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intact proviral DNA levels decline in people with HIV on antiretroviral therapy
by: J. Cyktor, et al.
Published: (2019)

OP 4.7 - 00121 Circulating immune predictors of intact HIV reservoir decay during long-term ART
by: M. Peluso, et al.
Published: (2022)

PP 1.7 - 00051 Continuous decline of intact proviral DNA after two decades of antiretroviral therapy
by: M. Nühn, et al.
Published: (2022)

PP 7.8 - 00060 Slowing or Reversal of Decay of Intact Proviruses Over Two Decades of Suppressive ART
by: J. Cyktor, et al.
Published: (2022)

Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform
by: Carolin Tumpach, et al.
Published: (2023)

SIV proviral landscape differs from that of HIV-1 and shows gross hypermutation
by: A.J. Murray, et al.
Published: (2017)

OP 3.6 - 00023 Effect of HIV-1 infection, viral particle production, and proviral integration site on CD4+ T cell proliferation
by: J. Kufera, et al.
Published: (2022)

OP 3.7 - 00099 Cohort-specific Adaptation of the Intact Proviral DNA Assay (IPDA) to HIV-1 subtypes A1, D, and recombinants
by: S.N. Gowanlock, et al.
Published: (2022)

Distinct HIV reservoir measures correlate with defective but not intact pro-viral DNA
by: E. Papasavvas, et al.
Published: (2019)

Intra- and inter-individual HIV diversity limits the application of the intact proviral detection assay (IPDA)
by: Natalie N. Kinloch, et al.
Published: (2019)

PP 1.19 - 00109 Differential decay dynamics of the inducible pool of HIV-1 infected CD4+ T cells and proviral DNA upon ART initiation revealed by the novel VIP-SPOT assay
by: M.C. Puertas, et al.
Published: (2022)

Contribution of antigenic exposure to the persistence of HIV-infected CD4 T cells in vivo
by: F. Simonetti, et al.
Published: (2019)

Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV
by: A.L. Hill, et al.
Published: (2015)

Differences in the proviral HIV DNA between HIV monoinfected and HIV/HCV coinfected individuals
by: M.S. Carrillo, et al.
Published: (2017)

14 Effect of substances of abuse on HIV DNA decay during antiretroviral therapy started during early HIV infection
by: A. Chaillon, et al.
Published: (2016)

Cellular proliferation maintains genetically intact and defective HIV-1 over time
by: B. Horsburgh, et al.
Published: (2019)

Intact HIV genomes are enriched in memory T cells with short half-lives
by: V. Morcilla, et al.
Published: (2019)

PP 3.9 - 00146 Impact of time on antiretroviral therapy on the proviral reservoir in people living with HIV
by: S. Rutsaert, et al.
Published: (2022)

PP 8.4 - 00061 Bispecific antibodies promote natural killer cell-mediated elimination of the HIV reservoir
by: N. Board, et al.
Published: (2022)

HIV integrates in genes regulating cell cycle, DNA damage, and viral transport
by: S. Lee, et al.
Published: (2017)

Enrichment of HIV proviral DNA from mononuclear leukocytes for next-generation sequencing of integration sites
by: C. Williams-Wietzikoski, et al.
Published: (2017)

17 HIV proviral DNA quantification in a cohort of Japanese patients on long-term ART
by: K. Stanoeva, et al.
Published: (2016)

Understanding persistence of the latent reservoir
by: R.F. Siliciano
Published: (2017)

Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
by: Michael J. Peluso, et al.
Published: (2020)

OP 3.2 - 00056 Clonally expanded HIV-1 proviruses with 5'-Leader defects can give rise to nonsuppressible residual viremia and complicate ART management
by: F. Wu, et al.
Published: (2022)

Characterising 'exceptional' control among HIV elite controllers
by: M. Peluso, et al.
Published: (2019)

CD4+ T cells expressing CD32 from HIV-1-positive patients are not enriched for proviral DNA
by: A.M. Spivak, et al.
Published: (2017)

Next generation viral outgrowth assays as proxies for classic QVOA to measure HIV-1 reservoir size
by: M. Stone, et al.
Published: (2017)

19 Quantification and correlates of the replication competent HIV-1 latent viral reservoir in a virally suppressed Ugandan population
by: J.L. Prodger, et al.
Published: (2016)

PP 3.17 - 00211 Genetic Diversity of HIV-1 Long Terminal Repeat in Proviral Populations During Long-Term Antiretroviral Therapy
by: T. Nguyen, et al.
Published: (2022)

Brief ATI does not alter the size or composition of the latent HIV-1 reservoir
by: K.J. Bar, et al.
Published: (2017)

Efforts to eliminate the latent reservoir in resting CD4+ T cells: strategies for curing HIV-1 infection
by: Ya-Chi Ho, et al.
Published: (2015)

PP 4.8 - 00108 Presentation of cognate antigens by dendritic cells causes stochastic HIV expression
by: M. Moskovljevic, et al.
Published: (2022)

Longitudinal proviral sequencing provides a window into selection pressures exerted on infected cells and provides an upper bound estimate of proviral half-lives which are influenced by expression and splicing potential
by: L. Cannon, et al.
Published: (2019)

Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1
by: Sara H. Osum, et al.
Published: (2023)

PP 3.5 - 00110 The proviral quasispecies of HIV-1
by: A. Telesnitsky, et al.
Published: (2022)

Proviral landscape in children parallels adults and enables reservoir reconstruction
by: J. Hasson, et al.
Published: (2019)

Diverse proviral structure of HIV integrants in clonally expanded cells
by: F.R. Simonetti, et al.
Published: (2015)

Single cell analysis of HIV latency reveals diverse proviral and host cell behaviour
by: E.P. Browne, et al.
Published: (2017)

PP 4.19 - 00021 Impact of SARS-COV-2-Mediated CD4 T Cell Activation HIV DNA Persistence In Vivo
by: T.-M. Deveau, et al.
Published: (2022)